Reply to discrepancies in drug approvals: A global dilemma

Cancer. 2015 Sep 15;121(18):3361-2. doi: 10.1002/cncr.29482. Epub 2015 Jun 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents*
  • Drug Approval*
  • Humans

Substances

  • Antineoplastic Agents